Treace Medical Concepts, Inc. (TMCI)
- Previous Close
5.63 - Open
5.75 - Bid 5.03 x 100
- Ask 5.07 x 2400
- Day's Range
5.03 - 5.75 - 52 Week Range
3.92 - 27.70 - Volume
1,154,245 - Avg. Volume
946,775 - Market Cap (intraday)
312.521M - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.88 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.60
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
www.treace.comRecent News: TMCI
Performance Overview: TMCI
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TMCI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TMCI
Valuation Measures
Market Cap
349.11M
Enterprise Value
309.21M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.77
Price/Book (mrq)
2.76
Enterprise Value/Revenue
1.58
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-27.93%
Return on Assets (ttm)
-14.33%
Return on Equity (ttm)
-38.55%
Revenue (ttm)
196.03M
Net Income Avi to Common (ttm)
-54.75M
Diluted EPS (ttm)
-0.88
Balance Sheet and Cash Flow
Total Cash (mrq)
110.01M
Total Debt/Equity (mrq)
55.47%
Levered Free Cash Flow (ttm)
-25.39M
Research Analysis: TMCI
Company Insights: TMCI
TMCI does not have Company Insights